PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.\', \'Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran. arab.hta@gmail.com.\', \'Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Pharmacology and Toxicology, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.\', \'MSN Labs Americas, Bogotá, Colombia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-90551-6
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34040117
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34040117>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34040117>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all